Global and United States Point of Care Infectious Disease Market Size, Status and Forecast 2020-2026

Global and United States Point of Care Infectious Disease Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point of Care Infectious Disease Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 HIV POC
1.2.3 Clostridium difficile POC
1.2.4 HBV POC
1.2.5 Pneumonia or Streptococcus associated infections
1.2.6 Respiratory syncytial virus (RSV) POC
1.2.7 HPV POC
1.2.8 Influenza/Flu POC
1.2.9 HCV POC
1.2.10 MRSA POC
1.2.11 TB and drug-resistant TB POC
1.3 Market by Application
1.3.1 Global Point of Care Infectious Disease Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home
1.3.5 Assisted Living Healthcare Facilities
1.3.6 Laboratories
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Point of Care Infectious Disease Market Perspective (2015-2026)
2.2 Global Point of Care Infectious Disease Growth Trends by Regions
2.2.1 Point of Care Infectious Disease Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Point of Care Infectious Disease Historic Market Share by Regions (2015-2020)
2.2.3 Point of Care Infectious Disease Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point of Care Infectious Disease Players by Market Size
3.1.1 Global Top Point of Care Infectious Disease Players by Revenue (2015-2020)
3.1.2 Global Point of Care Infectious Disease Revenue Market Share by Players (2015-2020)
3.2 Global Point of Care Infectious Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Point of Care Infectious Disease Revenue
3.4 Global Point of Care Infectious Disease Market Concentration Ratio
3.4.1 Global Point of Care Infectious Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point of Care Infectious Disease Revenue in 2019
3.5 Key Players Point of Care Infectious Disease Area Served
3.6 Key Players Point of Care Infectious Disease Product Solution and Service
3.7 Date of Enter into Point of Care Infectious Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point of Care Infectious Disease Breakdown Data by Type (2015-2026)
4.1 Global Point of Care Infectious Disease Historic Market Size by Type (2015-2020)
4.2 Global Point of Care Infectious Disease Forecasted Market Size by Type (2021-2026)
5 Point of Care Infectious Disease Breakdown Data by Application (2015-2026)
5.1 Global Point of Care Infectious Disease Historic Market Size by Application (2015-2020)
5.2 Global Point of Care Infectious Disease Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Point of Care Infectious Disease Market Size (2015-2026)
6.2 North America Point of Care Infectious Disease Market Size by Type (2015-2020)
6.3 North America Point of Care Infectious Disease Market Size by Application (2015-2020)
6.4 North America Point of Care Infectious Disease Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Point of Care Infectious Disease Market Size (2015-2026)
7.2 Europe Point of Care Infectious Disease Market Size by Type (2015-2020)
7.3 Europe Point of Care Infectious Disease Market Size by Application (2015-2020)
7.4 Europe Point of Care Infectious Disease Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Point of Care Infectious Disease Market Size (2015-2026)
8.2 China Point of Care Infectious Disease Market Size by Type (2015-2020)
8.3 China Point of Care Infectious Disease Market Size by Application (2015-2020)
8.4 China Point of Care Infectious Disease Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Point of Care Infectious Disease Market Size (2015-2026)
9.2 Japan Point of Care Infectious Disease Market Size by Type (2015-2020)
9.3 Japan Point of Care Infectious Disease Market Size by Application (2015-2020)
9.4 Japan Point of Care Infectious Disease Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Point of Care Infectious Disease Market Size (2015-2026)
10.2 Southeast Asia Point of Care Infectious Disease Market Size by Type (2015-2020)
10.3 Southeast Asia Point of Care Infectious Disease Market Size by Application (2015-2020)
10.4 Southeast Asia Point of Care Infectious Disease Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Siemens Healthineers
11.1.1 Siemens Healthineers Company Details
11.1.2 Siemens Healthineers Business Overview
11.1.3 Siemens Healthineers Point of Care Infectious Disease Introduction
11.1.4 Siemens Healthineers Revenue in Point of Care Infectious Disease Business (2015-2020))
11.1.5 Siemens Healthineers Recent Development
11.2 Trivitron Healthcare
11.2.1 Trivitron Healthcare Company Details
11.2.2 Trivitron Healthcare Business Overview
11.2.3 Trivitron Healthcare Point of Care Infectious Disease Introduction
11.2.4 Trivitron Healthcare Revenue in Point of Care Infectious Disease Business (2015-2020)
11.2.5 Trivitron Healthcare Recent Development
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Company Details
11.3.2 F. Hoffmann-La Roche Ltd Business Overview
11.3.3 F. Hoffmann-La Roche Ltd Point of Care Infectious Disease Introduction
11.3.4 F. Hoffmann-La Roche Ltd Revenue in Point of Care Infectious Disease Business (2015-2020)
11.3.5 F. Hoffmann-La Roche Ltd Recent Development
11.4 Abbott
11.4.1 Abbott Company Details
11.4.2 Abbott Business Overview
11.4.3 Abbott Point of Care Infectious Disease Introduction
11.4.4 Abbott Revenue in Point of Care Infectious Disease Business (2015-2020)
11.4.5 Abbott Recent Development
11.5 Quest Diagnostics, Inc
11.5.1 Quest Diagnostics, Inc Company Details
11.5.2 Quest Diagnostics, Inc Business Overview
11.5.3 Quest Diagnostics, Inc Point of Care Infectious Disease Introduction
11.5.4 Quest Diagnostics, Inc Revenue in Point of Care Infectious Disease Business (2015-2020)
11.5.5 Quest Diagnostics, Inc Recent Development
11.6 BD & Company
11.6.1 BD & Company Company Details
11.6.2 BD & Company Business Overview
11.6.3 BD & Company Point of Care Infectious Disease Introduction
11.6.4 BD & Company Revenue in Point of Care Infectious Disease Business (2015-2020)
11.6.5 BD & Company Recent Development
11.7 Chembio Diagnostics Inc
11.7.1 Chembio Diagnostics Inc Company Details
11.7.2 Chembio Diagnostics Inc Business Overview
11.7.3 Chembio Diagnostics Inc Point of Care Infectious Disease Introduction
11.7.4 Chembio Diagnostics Inc Revenue in Point of Care Infectious Disease Business (2015-2020)
11.7.5 Chembio Diagnostics Inc Recent Development
11.8 Trinity Biotech
11.8.1 Trinity Biotech Company Details
11.8.2 Trinity Biotech Business Overview
11.8.3 Trinity Biotech Point of Care Infectious Disease Introduction
11.8.4 Trinity Biotech Revenue in Point of Care Infectious Disease Business (2015-2020)
11.8.5 Trinity Biotech Recent Development
11.9 Cardinal Health
11.9.1 Cardinal Health Company Details
11.9.2 Cardinal Health Business Overview
11.9.3 Cardinal Health Point of Care Infectious Disease Introduction
11.9.4 Cardinal Health Revenue in Point of Care Infectious Disease Business (2015-2020)
11.9.5 Cardinal Health Recent Development
11.10 Bio-Rad Labs Inc.
11.10.1 Bio-Rad Labs Inc. Company Details
11.10.2 Bio-Rad Labs Inc. Business Overview
11.10.3 Bio-Rad Labs Inc. Point of Care Infectious Disease Introduction
11.10.4 Bio-Rad Labs Inc. Revenue in Point of Care Infectious Disease Business (2015-2020)
11.10.5 Bio-Rad Labs Inc. Recent Development
11.11 bioMérieux SA
10.11.1 bioMérieux SA Company Details
10.11.2 bioMérieux SA Business Overview
10.11.3 bioMérieux SA Point of Care Infectious Disease Introduction
10.11.4 bioMérieux SA Revenue in Point of Care Infectious Disease Business (2015-2020)
10.11.5 bioMérieux SA Recent Development
11.12 Thermo Fisher Scientific Inc
10.12.1 Thermo Fisher Scientific Inc Company Details
10.12.2 Thermo Fisher Scientific Inc Business Overview
10.12.3 Thermo Fisher Scientific Inc Point of Care Infectious Disease Introduction
10.12.4 Thermo Fisher Scientific Inc Revenue in Point of Care Infectious Disease Business (2015-2020)
10.12.5 Thermo Fisher Scientific Inc Recent Development
11.13 Sight Diagnostics Ltd.
10.13.1 Sight Diagnostics Ltd. Company Details
10.13.2 Sight Diagnostics Ltd. Business Overview
10.13.3 Sight Diagnostics Ltd. Point of Care Infectious Disease Introduction
10.13.4 Sight Diagnostics Ltd. Revenue in Point of Care Infectious Disease Business (2015-2020)
10.13.5 Sight Diagnostics Ltd. Recent Development
11.14 Gene POC
10.14.1 Gene POC Company Details
10.14.2 Gene POC Business Overview
10.14.3 Gene POC Point of Care Infectious Disease Introduction
10.14.4 Gene POC Revenue in Point of Care Infectious Disease Business (2015-2020)
10.14.5 Gene POC Recent Development
11.15 Ortho-Clinical Diagnostics
10.15.1 Ortho-Clinical Diagnostics Company Details
10.15.2 Ortho-Clinical Diagnostics Business Overview
10.15.3 Ortho-Clinical Diagnostics Point of Care Infectious Disease Introduction
10.15.4 Ortho-Clinical Diagnostics Revenue in Point of Care Infectious Disease Business (2015-2020)
10.15.5 Ortho-Clinical Diagnostics Recent Development
11.16 OJ-Bio Ltd.
10.16.1 OJ-Bio Ltd. Company Details
10.16.2 OJ-Bio Ltd. Business Overview
10.16.3 OJ-Bio Ltd. Point of Care Infectious Disease Introduction
10.16.4 OJ-Bio Ltd. Revenue in Point of Care Infectious Disease Business (2015-2020)
10.16.5 OJ-Bio Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Point of Care Infectious Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of HIV POC
Table 4. Key Players of Clostridium difficile POC
Table 5. Key Players of HBV POC
Table 6. Key Players of Pneumonia or Streptococcus associated infections
Table 7. Key Players of Respiratory syncytial virus (RSV) POC
Table 8. Key Players of HPV POC
Table 9. Key Players of Influenza/Flu POC
Table 10. Key Players of HCV POC
Table 11. Key Players of MRSA POC
Table 12. Key Players of TB and drug-resistant TB POC
Table 13. Global Point of Care Infectious Disease Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Point of Care Infectious Disease Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Point of Care Infectious Disease Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Point of Care Infectious Disease Market Share by Regions (2015-2020)
Table 17. Global Point of Care Infectious Disease Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Point of Care Infectious Disease Market Share by Regions (2021-2026)
Table 19. Point of Care Infectious Disease Market Market Trends
Table 20. Point of Care Infectious Disease Market Drivers
Table 21. Point of Care Infectious Disease Market Challenges
Table 22. Point of Care Infectious Disease Market Restraints
Table 23. Global Point of Care Infectious Disease Revenue by Players (2015-2020) (US$ Million)
Table 24. Global Point of Care Infectious Disease Market Share by Players (2015-2020)
Table 25. Global Top Point of Care Infectious Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point of Care Infectious Disease as of 2019)
Table 26. Global Point of Care Infectious Disease by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Point of Care Infectious Disease Product Solution and Service
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Point of Care Infectious Disease Market Size by Type (2015-2020) (US$ Million)
Table 31. Global Point of Care Infectious Disease Market Size Share by Type (2015-2020)
Table 32. Global Point of Care Infectious Disease Revenue Market Share by Type (2021-2026)
Table 33. Global Point of Care Infectious Disease Market Size Share by Application (2015-2020)
Table 34. Global Point of Care Infectious Disease Market Size by Application (2015-2020) (US$ Million)
Table 35. Global Point of Care Infectious Disease Market Size Share by Application (2021-2026)
Table 36. North America Point of Care Infectious Disease Market Size by Type (2015-2020) (US$ Million)
Table 37. North America Point of Care Infectious Disease Market Share by Type (2015-2020)
Table 38. North America Point of Care Infectious Disease Market Size by Application (2015-2020) (US$ Million)
Table 39. North America Point of Care Infectious Disease Market Share by Application (2015-2020)
Table 40. North America Point of Care Infectious Disease Market Size by Country (US$ Million) (2015-2020)
Table 41. North America Point of Care Infectious Disease Market Share by Country (2015-2020)
Table 42. Europe Point of Care Infectious Disease Market Size by Type (2015-2020) (US$ Million)
Table 43. Europe Point of Care Infectious Disease Market Share by Type (2015-2020)
Table 44. Europe Point of Care Infectious Disease Market Size by Application (2015-2020) (US$ Million)
Table 45. Europe Point of Care Infectious Disease Market Share by Application (2015-2020)
Table 46. Europe Point of Care Infectious Disease Market Size by Country (US$ Million) (2015-2020)
Table 47. Europe Point of Care Infectious Disease Market Share by Country (2015-2020)
Table 48. China Point of Care Infectious Disease Market Size by Type (2015-2020) (US$ Million)
Table 49. China Point of Care Infectious Disease Market Share by Type (2015-2020)
Table 50. China Point of Care Infectious Disease Market Size by Application (2015-2020) (US$ Million)
Table 51. China Point of Care Infectious Disease Market Share by Application (2015-2020)
Table 52. China Point of Care Infectious Disease Market Size by Region (US$ Million) (2015-2020)
Table 53. China Point of Care Infectious Disease Market Share by Region (2015-2020)
Table 54. Japan Point of Care Infectious Disease Market Size by Type (2015-2020) (US$ Million)
Table 55. Japan Point of Care Infectious Disease Market Share by Type (2015-2020)
Table 56. Japan Point of Care Infectious Disease Market Size by Application (2015-2020) (US$ Million)
Table 57. Japan Point of Care Infectious Disease Market Share by Application (2015-2020)
Table 58. Japan Point of Care Infectious Disease Market Size by Country (US$ Million) (2015-2020)
Table 59. Japan Point of Care Infectious Disease Market Share by Country (2015-2020)
Table 60. Southeast Asia Point of Care Infectious Disease Market Size by Type (2015-2020) (US$ Million)
Table 61. Southeast Asia Point of Care Infectious Disease Market Share by Type (2015-2020)
Table 62. Southeast Asia Point of Care Infectious Disease Market Size by Application (2015-2020) (US$ Million)
Table 63. Southeast Asia Point of Care Infectious Disease Market Share by Application (2015-2020)
Table 64. Southeast Asia Point of Care Infectious Disease Market Size by Country (US$ Million) (2015-2020)
Table 65. Southeast Asia Point of Care Infectious Disease Market Share by Country (2015-2020)
Table 66. Siemens Healthineers Company Details
Table 67. Siemens Healthineers Business Overview
Table 68. Siemens Healthineers Product
Table 69. Siemens Healthineers Revenue in Point of Care Infectious Disease Business (2015-2020) (US$ Million)
Table 70. Siemens Healthineers Recent Development
Table 71. Trivitron Healthcare Company Details
Table 72. Trivitron Healthcare Business Overview
Table 73. Trivitron Healthcare Product
Table 74. Trivitron Healthcare Revenue in Point of Care Infectious Disease Business (2015-2020) (US$ Million)
Table 75. Trivitron Healthcare Recent Development
Table 76. F. Hoffmann-La Roche Ltd Company Details
Table 77. F. Hoffmann-La Roche Ltd Business Overview
Table 78. F. Hoffmann-La Roche Ltd Product
Table 79. F. Hoffmann-La Roche Ltd Revenue in Point of Care Infectious Disease Business (2015-2020) (US$ Million)
Table 80. F. Hoffmann-La Roche Ltd Recent Development
Table 81. Abbott Company Details
Table 82. Abbott Business Overview
Table 83. Abbott Product
Table 84. Abbott Revenue in Point of Care Infectious Disease Business (2015-2020) (US$ Million)
Table 85. Abbott Recent Development
Table 86. Quest Diagnostics, Inc Company Details
Table 87. Quest Diagnostics, Inc Business Overview
Table 88. Quest Diagnostics, Inc Product
Table 89. Quest Diagnostics, Inc Revenue in Point of Care Infectious Disease Business (2015-2020) (US$ Million)
Table 90. Quest Diagnostics, Inc Recent Development
Table 91. BD & Company Company Details
Table 92. BD & Company Business Overview
Table 93. BD & Company Product
Table 94. BD & Company Revenue in Point of Care Infectious Disease Business (2015-2020) (US$ Million)
Table 95. BD & Company Recent Development
Table 96. Chembio Diagnostics Inc Company Details
Table 97. Chembio Diagnostics Inc Business Overview
Table 98. Chembio Diagnostics Inc Product
Table 99. Chembio Diagnostics Inc Revenue in Point of Care Infectious Disease Business (2015-2020) (US$ Million)
Table 100. Chembio Diagnostics Inc Recent Development
Table 101. Trinity Biotech Business Overview
Table 102. Trinity Biotech Product
Table 103. Trinity Biotech Company Details
Table 104. Trinity Biotech Revenue in Point of Care Infectious Disease Business (2015-2020) (US$ Million)
Table 105. Trinity Biotech Recent Development
Table 106. Cardinal Health Company Details
Table 107. Cardinal Health Business Overview
Table 108. Cardinal Health Product
Table 109. Cardinal Health Revenue in Point of Care Infectious Disease Business (2015-2020) (US$ Million)
Table 110. Cardinal Health Recent Development
Table 111. Bio-Rad Labs Inc. Company Details
Table 112. Bio-Rad Labs Inc. Business Overview
Table 113. Bio-Rad Labs Inc. Product
Table 114. Bio-Rad Labs Inc. Revenue in Point of Care Infectious Disease Business (2015-2020) (US$ Million)
Table 115. Bio-Rad Labs Inc. Recent Development
Table 116. bioMérieux SA Company Details
Table 117. bioMérieux SA Business Overview
Table 118. bioMérieux SA Product
Table 119. bioMérieux SA Revenue in Point of Care Infectious Disease Business (2015-2020) (US$ Million)
Table 120. bioMérieux SA Recent Development
Table 121. Thermo Fisher Scientific Inc Company Details
Table 122. Thermo Fisher Scientific Inc Business Overview
Table 123. Thermo Fisher Scientific Inc Product
Table 124. Thermo Fisher Scientific Inc Revenue in Point of Care Infectious Disease Business (2015-2020) (US$ Million)
Table 125. Thermo Fisher Scientific Inc Recent Development
Table 126. Sight Diagnostics Ltd. Company Details
Table 127. Sight Diagnostics Ltd. Business Overview
Table 128. Sight Diagnostics Ltd. Product
Table 129. Sight Diagnostics Ltd. Revenue in Point of Care Infectious Disease Business (2015-2020) (US$ Million)
Table 130. Sight Diagnostics Ltd. Recent Development
Table 131. Gene POC Company Details
Table 132. Gene POC Business Overview
Table 133. Gene POC Product
Table 134. Gene POC Revenue in Point of Care Infectious Disease Business (2015-2020) (US$ Million)
Table 135. Gene POC Recent Development
Table 136. Ortho-Clinical Diagnostics Company Details
Table 137. Ortho-Clinical Diagnostics Business Overview
Table 138. Ortho-Clinical Diagnostics Product
Table 139. Ortho-Clinical Diagnostics Revenue in Point of Care Infectious Disease Business (2015-2020) (US$ Million)
Table 140. Ortho-Clinical Diagnostics Recent Development
Table 141. OJ-Bio Ltd. Company Details
Table 142. OJ-Bio Ltd. Business Overview
Table 143. OJ-Bio Ltd. Product
Table 144. OJ-Bio Ltd. Revenue in Point of Care Infectious Disease Business (2015-2020) (US$ Million)
Table 145. OJ-Bio Ltd. Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Point of Care Infectious Disease Market Share by Type: 2020 VS 2026
Figure 2. HIV POC Features
Figure 3. Clostridium difficile POC Features
Figure 4. HBV POC Features
Figure 5. Pneumonia or Streptococcus associated infections Features
Figure 6. Respiratory syncytial virus (RSV) POC Features
Figure 7. HPV POC Features
Figure 8. Influenza/Flu POC Features
Figure 9. HCV POC Features
Figure 10. MRSA POC Features
Figure 11. TB and drug-resistant TB POC Features
Figure 12. Global Point of Care Infectious Disease Market Share by Application: 2020 VS 2026
Figure 13. Hospitals Case Studies
Figure 14. Clinics Case Studies
Figure 15. Home Case Studies
Figure 16. Assisted Living Healthcare Facilities Case Studies
Figure 17. Laboratories Case Studies
Figure 18. Others Case Studies
Figure 19. Point of Care Infectious Disease Report Years Considered
Figure 20. Global Point of Care Infectious Disease Market Size (US$ Million), YoY Growth 2015-2026
Figure 21. Global Point of Care Infectious Disease Market Share by Regions: 2020 VS 2026
Figure 22. Global Point of Care Infectious Disease Market Share by Regions (2021-2026)
Figure 23. Global Point of Care Infectious Disease Market Share by Players in 2019
Figure 24. Global Top Point of Care Infectious Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point of Care Infectious Disease as of 2019
Figure 25. The Top 10 and 5 Players Market Share by Point of Care Infectious Disease Revenue in 2019
Figure 26. North America Point of Care Infectious Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. United States Point of Care Infectious Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Canada Point of Care Infectious Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Europe Point of Care Infectious Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Germany Point of Care Infectious Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. France Point of Care Infectious Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. U.K. Point of Care Infectious Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Italy Point of Care Infectious Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Russia Point of Care Infectious Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Nordic Point of Care Infectious Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Rest of Europe Point of Care Infectious Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Asia-Pacific Point of Care Infectious Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. China Point of Care Infectious Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Japan Point of Care Infectious Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. South Korea Point of Care Infectious Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Southeast Asia Point of Care Infectious Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. India Point of Care Infectious Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Australia Point of Care Infectious Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Rest of Asia-Pacific Point of Care Infectious Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Latin America Point of Care Infectious Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 46. Mexico Point of Care Infectious Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 47. Brazil Point of Care Infectious Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 48. Middle East & Africa Point of Care Infectious Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 49. Turkey Point of Care Infectious Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 50. Saudi Arabia Point of Care Infectious Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 51. UAE Point of Care Infectious Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 52. Rest of Middle East & Africa Point of Care Infectious Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 53. Siemens Healthineers Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 54. Trivitron Healthcare Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 55. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 56. Abbott Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 57. Quest Diagnostics, Inc Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 58. BD & Company Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 59. Chembio Diagnostics Inc Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 60. Trinity Biotech Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 61. Cardinal Health Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 62. Bio-Rad Labs Inc. Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 63. bioMérieux SA Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 64. Thermo Fisher Scientific Inc Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 65. Sight Diagnostics Ltd. Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 66. Gene POC Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 67. Ortho-Clinical Diagnostics Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 68. OJ-Bio Ltd. Revenue Growth Rate in Point of Care Infectious Disease Business (2015-2020)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs